A detailed history of Neuberger Berman Group LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 942,135 shares of ATRC stock, worth $33.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
942,135
Previous 868,437 8.49%
Holding current value
$33.9 Million
Previous $19.8 Million 33.59%
% of portfolio
0.02%
Previous 0.02%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$20.34 - $29.5 $1.5 Million - $2.17 Million
73,698 Added 8.49%
942,135 $26.4 Million
Q2 2024

Nov 14, 2024

BUY
$19.86 - $29.09 $1.6 Million - $2.34 Million
80,464 Added 10.21%
868,437 $19.8 Million
Q2 2024

Aug 13, 2024

BUY
$19.86 - $29.09 $1.6 Million - $2.34 Million
80,464 Added 10.21%
868,437 $19.8 Million
Q1 2024

Nov 14, 2024

BUY
$28.21 - $37.78 $811,093 - $1.09 Million
28,752 Added 3.79%
787,973 $24 Million
Q1 2024

May 13, 2024

BUY
$28.21 - $37.78 $22.2 Million - $29.8 Million
787,973 New
787,973 $24 Million
Q4 2023

Nov 14, 2024

SELL
$32.99 - $43.25 $3.6 Million - $4.72 Million
-109,216 Reduced 12.58%
759,221 $27.1 Million
Q4 2023

Feb 09, 2024

SELL
$32.99 - $43.25 $158,220 - $207,427
-4,796 Reduced 0.63%
759,221 $27.1 Million
Q3 2023

Nov 14, 2023

BUY
$41.12 - $57.73 $134,709 - $189,123
3,276 Added 0.43%
764,017 $33.5 Million
Q2 2023

Aug 11, 2023

BUY
$40.44 - $49.6 $285,991 - $350,771
7,072 Added 0.94%
760,741 $37.6 Million
Q1 2023

May 12, 2023

BUY
$35.87 - $47.22 $7.32 Million - $9.64 Million
204,175 Added 37.16%
753,669 $31.2 Million
Q4 2022

Feb 13, 2023

BUY
$33.48 - $47.45 $234,627 - $332,529
7,008 Added 1.29%
549,494 $24.4 Million
Q3 2022

Nov 15, 2022

BUY
$38.25 - $52.62 $1.23 Million - $1.7 Million
32,226 Added 6.32%
542,486 $21.2 Million
Q2 2022

Aug 15, 2022

BUY
$35.1 - $66.01 $663,003 - $1.25 Million
18,889 Added 3.84%
510,260 $20.8 Million
Q1 2022

May 13, 2022

SELL
$57.43 - $71.39 $683,933 - $850,183
-11,909 Reduced 2.37%
491,371 $31.7 Million
Q4 2021

Feb 11, 2022

BUY
$63.4 - $87.14 $23,077 - $31,718
364 Added 0.07%
503,280 $34.4 Million
Q3 2021

Nov 12, 2021

SELL
$69.28 - $84.46 $583,337 - $711,153
-8,420 Reduced 1.65%
502,916 $34.4 Million
Q2 2021

Aug 13, 2021

SELL
$64.13 - $80.18 $8.27 Million - $10.3 Million
-129,031 Reduced 20.15%
511,336 $40.1 Million
Q1 2021

May 13, 2021

SELL
$53.79 - $66.98 $3.85 Million - $4.79 Million
-71,582 Reduced 10.05%
640,367 $41.6 Million
Q4 2020

Feb 10, 2021

SELL
$34.56 - $57.55 $759,663 - $1.27 Million
-21,981 Reduced 2.99%
711,949 $39.4 Million
Q3 2020

Nov 12, 2020

SELL
$38.36 - $46.91 $423,954 - $518,449
-11,052 Reduced 1.48%
733,930 $29.3 Million
Q2 2020

Aug 13, 2020

SELL
$31.78 - $51.19 $3.18 Million - $5.12 Million
-100,073 Reduced 11.84%
744,982 $33.5 Million
Q1 2020

May 14, 2020

SELL
$24.49 - $43.84 $173,462 - $310,518
-7,083 Reduced 0.83%
845,055 $28.4 Million
Q4 2019

Feb 12, 2020

BUY
$24.06 - $32.51 $2.19 Million - $2.96 Million
91,059 Added 11.96%
852,138 $27.7 Million
Q3 2019

Nov 13, 2019

BUY
$23.81 - $32.52 $868,422 - $1.19 Million
36,473 Added 5.03%
761,079 $19 Million
Q2 2019

Aug 13, 2019

SELL
$26.85 - $30.74 $209,993 - $240,417
-7,821 Reduced 1.07%
724,606 $21.6 Million
Q1 2019

May 13, 2019

BUY
$26.38 - $33.34 $200,408 - $253,283
7,597 Added 1.05%
732,427 $19.6 Million
Q4 2018

Feb 12, 2019

SELL
$26.66 - $34.85 $306,563 - $400,740
-11,499 Reduced 1.56%
724,830 $22.2 Million
Q3 2018

Nov 13, 2018

SELL
$27.62 - $35.58 $668,321 - $860,929
-24,197 Reduced 3.18%
736,329 $25.8 Million
Q2 2018

Aug 13, 2018

SELL
$19.65 - $30.28 $380,011 - $585,584
-19,339 Reduced 2.48%
760,526 $20.6 Million
Q1 2018

May 08, 2018

SELL
$15.05 - $21.03 $551,717 - $770,938
-36,659 Reduced 4.49%
779,865 $16 Million
Q4 2017

Feb 14, 2018

SELL
$17.69 - $23.44 $1.48 Million - $1.96 Million
-83,772 Reduced 9.3%
816,524 $14.9 Million
Q3 2017

Nov 15, 2017

BUY
$20.0 - $24.23 $18 Million - $21.8 Million
900,296
900,296 $20.1 Million

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.67B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.